Literature DB >> 22867847

Cholesterol and breast cancer development.

Christiane Danilo1, Philippe G Frank.   

Abstract

Breast cancer is the most commonly occurring type of cancer in the world. Among the environmental factors believed to be responsible for this phenomenon, cholesterol has recently received considerable attention. Epidemiologic studies have provided inconclusive results, indicating that there may be a relationship between abnormal plasma cholesterol levels and breast cancer risk. However, more compelling evidence has been obtained in laboratory studies, and they indicate that cholesterol is capable of regulating proliferation, migration, and signaling pathways in breast cancer. In vivo studies have also indicated that plasma cholesterol levels can regulate tumor growth in mouse models. The recognition of cholesterol as a factor contributing to breast cancer development identifies cholesterol and its metabolism as novel targets for cancer therapy.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22867847     DOI: 10.1016/j.coph.2012.07.009

Source DB:  PubMed          Journal:  Curr Opin Pharmacol        ISSN: 1471-4892            Impact factor:   5.547


  54 in total

1.  Hypercholesterolemia induces angiogenesis and accelerates growth of breast tumors in vivo.

Authors:  Kristine Pelton; Christine M Coticchia; Adam S Curatolo; Carl P Schaffner; David Zurakowski; Keith R Solomon; Marsha A Moses
Journal:  Am J Pathol       Date:  2014-07       Impact factor: 4.307

2.  Obesity, cholesterol metabolism, and breast cancer pathogenesis.

Authors:  Donald P McDonnell; Sunghee Park; Matthew T Goulet; Jeff Jasper; Suzanne E Wardell; Ching-Yi Chang; John D Norris; John R Guyton; Erik R Nelson
Journal:  Cancer Res       Date:  2014-07-24       Impact factor: 12.701

Review 3.  The significance of cholesterol and its metabolite, 27-hydroxycholesterol in breast cancer.

Authors:  Erik R Nelson
Journal:  Mol Cell Endocrinol       Date:  2017-09-15       Impact factor: 4.102

Review 4.  Lipid rafts as signaling hubs in cancer cell survival/death and invasion: implications in tumor progression and therapy: Thematic Review Series: Biology of Lipid Rafts.

Authors:  Faustino Mollinedo; Consuelo Gajate
Journal:  J Lipid Res       Date:  2020-11-07       Impact factor: 5.922

5.  Comorbidities: Cardiovascular disease and breast cancer.

Authors:  Melissa Moey; Javid Moslehi
Journal:  Nat Rev Cardiol       Date:  2018-03-13       Impact factor: 32.419

Review 6.  Synthetic high-density lipoprotein-like nanoparticles as cancer therapy.

Authors:  Kaylin M McMahon; Linda Foit; Nicholas L Angeloni; Francis J Giles; Leo I Gordon; C Shad Thaxton
Journal:  Cancer Treat Res       Date:  2015

7.  The antitumor efficacy of docetaxel is enhanced by encapsulation in novel amphiphilic polymer cholesterol-coupled tocopheryl polyethylene glycol 1000 succinate micelles.

Authors:  Qingjing Tian; Jia Shi; Xiaoyun Zhao; Donghua Di; Yihui Deng; Yanzhi Song
Journal:  Drug Deliv Transl Res       Date:  2017-10       Impact factor: 4.617

Review 8.  Lipid rafts as signaling hubs in cancer cell survival/death and invasion: implications in tumor progression and therapy.

Authors:  Faustino Mollinedo; Consuelo Gajate
Journal:  J Lipid Res       Date:  2020-01-27       Impact factor: 5.922

Review 9.  Synthetic high-density lipoprotein-like nanoparticles for cancer therapy.

Authors:  Linda Foit; Francis J Giles; Leo I Gordon; Colby Shad Thaxton
Journal:  Expert Rev Anticancer Ther       Date:  2014-12-09       Impact factor: 4.512

10.  Annexin A6 and Late Endosomal Cholesterol Modulate Integrin Recycling and Cell Migration.

Authors:  Ana García-Melero; Meritxell Reverter; Monira Hoque; Elsa Meneses-Salas; Meryem Koese; James R W Conway; Camilla H Johnsen; Anna Alvarez-Guaita; Frederic Morales-Paytuvi; Yasmin A Elmaghrabi; Albert Pol; Francesc Tebar; Rachael Z Murray; Paul Timpson; Carlos Enrich; Thomas Grewal; Carles Rentero
Journal:  J Biol Chem       Date:  2015-11-17       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.